Salt-inducible kinase 1 is involved in high glucose-induced mesangial cell proliferation mediated by the ALK5 signaling pathway

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 151-157

  Yu, Jie ^a,b   Hu, Xiaopeng ^a   Yang, Zhengdong ^a   Takemori, Hiroshi ^c   Li, Yanhong ^a   Zheng, Huan ^a   Hong, Shicong ^a   Liao, Qiuhong ^a   Wen, Xiuying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First People's Hospital of Jiujiang City   (China)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Activin receptor like kinase 5 signaling pathway; Cell proliferation; Extracellular matrix accumulation; Salt inducible kinase 1

Indexed keywords

FIBRONECTIN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SERINE THREONINE KINASE; SALT INDUCIBLE KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DOWN REGULATION; EXTRACELLULAR MATRIX; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLUCOSE; MESANGIAL CELLS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 84878232025     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1377     Document Type: Article

References (34)

1. Border WA and Noble NA: Evidence that TGF-β should be a therapeutic target in diabetic nephropathy. Kidney Int 54: 1390-1391, 1998. (Pubitemid 28449932)
2. Ayo SH, Radnik RA, Glass W, et al: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-F191, 1991.
3. Paradis V, Perlemuter G, Bonvoust F, et al: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34: 738-744, 2001. (Pubitemid 32927998)
4. Schnaper HW, Hayashida T, Hubchak SC and Poncelet AC: TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 284: F243-F252, 2003. (Pubitemid 36114687)
5. Lebrin F, Deckers M, Bertolino P and Ten Dijke P: TGF-β receptor function in the endothelium. Cardiovasc Res 65: 599-608, 2005.
6. Moon J, Kim H, Cho I, Sheen Y and Kim D: IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 70: 1234-1243, 2006. (Pubitemid 44435174)
7. Laping NJ: ALK5 inhibition in renal disease. Curr Opin Pharmacol 3: 204-208, 2003.
8. Wang Z, Takemori H, Halder SK, Nonaka Y and Okamoto M: Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett 453: 135-139, 1999. (Pubitemid 29335487)
9. Steinberg GR and Kemp BE: AMPK in health and disease. Physiol Rev 89: 1025-1078, 2009.
10. Takemori H, Katoh Y, Horike N, Doi J and Okamoto M: ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. J Biol Chem 277: 42334-42343, 2002.
11. Hashimoto YK, Satoh T, Okamoto M and Takemori H: Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J Cell Biochem 104: 1724-1739, 2008.
12. Al-Hakim AK, Goransson O, Deak M, et al: 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J Cell Sci 118: 5661-5673, 2005. (Pubitemid 43079304)
13. Romito A, Lonardo E, Roma G, Minchiotti G, Ballabio A and Cobellis G: Lack of sik1 in mouse embryonic stem cells impairs cardiomyogenesis by down-regulating the cyclin-dependent kinase inhibitor p57kip2. PloS One 5: e9029, 2010.
14. Berdeaux R, Goebel N, Banaszynski L, et al: SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med 13: 597-603, 2007. (Pubitemid 46828484)
15. Cheng H, Liu P, Wang ZC, et al: SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci Signal 2: ra35, 2009.
16. Koo SH, Flechner L, Qi L, et al: The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437: 1109-1111, 2005.
17. Yoon YS, Seo WY, Lee MW, Kim ST and Koo SH: Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation. J Biol Chem 284: 10446-10452, 2009.
18. Kowanetz M, Lönn P, Vanlandewijck M, Kowanetz K, Heldin CH and Moustakas A: TGFβ induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol 182: 655-662, 2008.
19. Lönn P, Vanlandewijck M, Raja E, et al: Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase. J Biol Chem 287: 12867-12878, 2012.
20. Feldman JD, Vician L, Crispino M, Hoe W, Baudry M and Herschman HR: The Salt-inducible kinase, SIK, is induced by depolarization in brain. J Neurochem 74: 2227-2238, 2002. (Pubitemid 30314197)
21. Wen X, Zeng Y, Liu L, et al: Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol 142: 144-150, 2012.
22. Huang W, Yu J, Jia X, Xiong L, Li N and Wen X: Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats. Am J Chin Med 40: 721-733, 2012.
23. Wang S and Hirschberg R: Diabetes-relevant regulation of cultured blood outgrowth endothelial cells. Microvasc Res 78: 174-179, 2009.
24. Hills CE, Al-Rasheed N, Willars GB and Brunskill NJ: C-peptide reverses TGF-β1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am J Physiol Renal Physiol 296: F614-F621, 2009.
25. Du J, Chen Q, Takemori H and Xu H: SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity (Silver Spring) 16: 531-538, 2008. (Pubitemid 351328002)
26. Lee MJ, Feliers D, Sataranatarajan K, et al: Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 22: 65-70, 2010.
27. Lin X, Takemori H, Katoh Y, et al: Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells. Mol Endocrinol 15: 1264-1276, 2001. (Pubitemid 32703476)
28. Katoh Y, Takemori H, Lin X, et al: Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 273: 2730-2748, 2006.
29. Sasaki T, Takemori H, Yagita Y, et al: SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69: 106-119, 2011.
30. Xu J, Wu Y, Song P, Zhang M, Wang S and Zou MH: Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116: 944-953, 2007. (Pubitemid 47300919)
31. Trumper A, Trumper K and Horsch D: Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta (INS-1)-cells. J Endocrinol 174: 233-246, 2002. (Pubitemid 34965762)
32. Wu L and Derynck R: Essential role of TGF-β signaling in glucose-induced cell hypertrophy. Dev Cell 17: 35-48, 2009.
33. Gouville AC, Boullay V, Krysa G, et al: Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 145: 166-177, 2009. (Pubitemid 40756521)
34. Yata Y, Gotwals P, Koteliansky V and Rockey DC: Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: implications for antifibrotic therapy. Hepatology 35: 1022-1030, 2002. (Pubitemid 34453999)